Olink Holding AB (publ) Return on Tangible Equity 2020-2023 | OLK
Current and historical return on tangible equity values for Olink Holding AB (publ) (OLK) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Olink Holding AB (publ) Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $-0.03B | $0.24B | -13.57% |
| 2023-09-30 | $-0.02B | $0.23B | -8.92% |
| 2023-06-30 | $-0.02B | $0.23B | -9.51% |
| 2023-03-31 | $-0.02B | $0.24B | -8.92% |
| 2022-12-31 | $-0.01B | $0.15B | -8.84% |
| 2022-09-30 | $-0.03B | $0.14B | -19.90% |
| 2022-06-30 | $-0.03B | $0.14B | -21.18% |
| 2022-03-31 | $-0.04B | $0.16B | -23.36% |
| 2021-12-31 | $-0.04B | $0.17B | -23.46% |
| 2021-09-30 | $-0.02B | $0.18B | -19.20% |
| 2021-06-30 | $-0.02B | $0.19B | -28.31% |
| 2021-03-31 | $-0.02B | $0.19B | -51.80% |
| 2020-12-31 | $-0.02B | $-0.05B | 158.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.910B | $0.170B |
| Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
| Inspire Medical Systems (INSP) | United States | $5.181B | 0.00 |
| Axonics (AXNX) | United States | $3.439B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
| Azenta (AZTA) | United States | $2.928B | 159.12 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Hims & Hers Health (HIMS) | United States | $2.768B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 120.20 |
| Schrodinger (SDGR) | United States | $1.673B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 48.02 |
| Phreesia (PHR) | United States | $1.238B | 0.00 |
| Standard BioTools (LAB) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
| Talkspace (TALK) | United States | $0.483B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.231B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
| Outset Medical (OM) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.152B | 0.00 |
| TruBridge (TBRG) | United States | $0.123B | 5.26 |
| Augmedix (AUGX) | United States | $0.122B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| CareCloud (CCLD) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |